Although the pathophysiological mechanism of depression-like behaviors in the STZ-induced AD model is unclear, some pilot research indicated that the activation of indoleamine-2,3-dioxygenase (IDO) might be a key factor [14]. The gene discussed is IDO1; the disease is depressive symptom measurement.